LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more
Cellares and ProTgen Automate Manufacturing of Progenitor T-Cell Therapy for Blood Cancer
Cellares, an Integrated Development and Manufacturing Organization (IDMO) that combines automated manufacturing platforms with global Smart Factory infrastructure, and ProTgen, a therapeutic company pioneering targeted Notch
